Eintrag weiter verarbeiten
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
Gespeichert in:
| Zeitschriftentitel: | Cancer Prevention Research |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| In: | Cancer Prevention Research, 8, 2015, 12, S. 1156-1162 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Association for Cancer Research (AACR)
|
| Schlagwörter: |
| author_facet |
Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. |
|---|---|
| author |
Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. |
| spellingShingle |
Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. Cancer Prevention Research NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project Cancer Research Oncology |
| author_sort |
petrick, jessica l. |
| spelling |
Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. 1940-6207 1940-6215 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1940-6207.capr-15-0126 <jats:title>Abstract</jats:title> <jats:p>Chronic inflammation plays a pivotal role in the pathogenesis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), the two most common types of liver cancer. A number of prior experimental studies have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may potentially protect against liver cancer. However, no observational study has examined the association between aspirin duration and dose or other over-the-counter non-aspirin NSAIDs, such as ibuprofen, and liver cancer incidence. Furthermore, the association between NSAID use and risk of ICC is unclear. As part of the Liver Cancer Pooling Project, we harmonized data on 1,084,133 individuals (HCC = 679, ICC = 225) from 10 U.S.-based prospective cohort studies. Cox proportional hazards regression models were used to evaluate multivariable-adjusted HRs and 95% confidence intervals (CI). Current aspirin use, versus nonuse, was inversely associated with HCC (HR, 0.68; 95% CI, 0.57–0.81), which persisted when restricted to individuals not using non-aspirin NSAIDs and in a 5- and 10-year lag analysis. The association between aspirin use and HCC risk was stronger for users who reported daily use, longer duration use, and lower dosage. Ibuprofen use was not associated with HCC risk. Aspirin use was associated with a reduced ICC risk in men (HR, 0.64; 95% CI, 0.42–0.98) but not women (HR, 1.34; 95% CI, 0.89–2.01; Pinteraction = 0.01). The observed inverse association between aspirin use and liver cancer in our study, together with previous data, suggests the merit of future intervention studies of aspirin and other agents that affect chronic inflammatory pathways for HCC and possibly ICC. Cancer Prev Res; 8(12); 1156–62. ©2015 AACR.</jats:p> NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project Cancer Prevention Research |
| doi_str_mv |
10.1158/1940-6207.capr-15-0126 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xNS0wMTI2 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xNS0wMTI2 |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
American Association for Cancer Research (AACR), 2015 |
| imprint_str_mv |
American Association for Cancer Research (AACR), 2015 |
| issn |
1940-6207 1940-6215 |
| issn_str_mv |
1940-6207 1940-6215 |
| language |
English |
| mega_collection |
American Association for Cancer Research (AACR) (CrossRef) |
| match_str |
petrick2015nsaiduseandriskofhepatocellularcarcinomaandintrahepaticcholangiocarcinomathelivercancerpoolingproject |
| publishDateSort |
2015 |
| publisher |
American Association for Cancer Research (AACR) |
| recordtype |
ai |
| record_format |
ai |
| series |
Cancer Prevention Research |
| source_id |
49 |
| title |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_unstemmed |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_full |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_fullStr |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_full_unstemmed |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_short |
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_sort |
nsaid use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1158/1940-6207.capr-15-0126 |
| publishDate |
2015 |
| physical |
1156-1162 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>Chronic inflammation plays a pivotal role in the pathogenesis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), the two most common types of liver cancer. A number of prior experimental studies have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may potentially protect against liver cancer. However, no observational study has examined the association between aspirin duration and dose or other over-the-counter non-aspirin NSAIDs, such as ibuprofen, and liver cancer incidence. Furthermore, the association between NSAID use and risk of ICC is unclear. As part of the Liver Cancer Pooling Project, we harmonized data on 1,084,133 individuals (HCC = 679, ICC = 225) from 10 U.S.-based prospective cohort studies. Cox proportional hazards regression models were used to evaluate multivariable-adjusted HRs and 95% confidence intervals (CI). Current aspirin use, versus nonuse, was inversely associated with HCC (HR, 0.68; 95% CI, 0.57–0.81), which persisted when restricted to individuals not using non-aspirin NSAIDs and in a 5- and 10-year lag analysis. The association between aspirin use and HCC risk was stronger for users who reported daily use, longer duration use, and lower dosage. Ibuprofen use was not associated with HCC risk. Aspirin use was associated with a reduced ICC risk in men (HR, 0.64; 95% CI, 0.42–0.98) but not women (HR, 1.34; 95% CI, 0.89–2.01; Pinteraction = 0.01). The observed inverse association between aspirin use and liver cancer in our study, together with previous data, suggests the merit of future intervention studies of aspirin and other agents that affect chronic inflammatory pathways for HCC and possibly ICC. Cancer Prev Res; 8(12); 1156–62. ©2015 AACR.</jats:p> |
| container_issue |
12 |
| container_start_page |
1156 |
| container_title |
Cancer Prevention Research |
| container_volume |
8 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792348783138308107 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T18:16:40.501Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=NSAID+Use+and+Risk+of+Hepatocellular+Carcinoma+and+Intrahepatic+Cholangiocarcinoma%3A+The+Liver+Cancer+Pooling+Project&rft.date=2015-12-01&genre=article&issn=1940-6215&volume=8&issue=12&spage=1156&epage=1162&pages=1156-1162&jtitle=Cancer+Prevention+Research&atitle=NSAID+Use+and+Risk+of+Hepatocellular+Carcinoma+and+Intrahepatic+Cholangiocarcinoma%3A+The+Liver+Cancer+Pooling+Project&aulast=McGlynn&aufirst=Katherine+A.&rft_id=info%3Adoi%2F10.1158%2F1940-6207.capr-15-0126&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792348783138308107 |
| author | Petrick, Jessica L., Sahasrabuddhe, Vikrant V., Chan, Andrew T., Alavanja, Michael C., Beane-Freeman, Laura E., Buring, Julie E., Chen, Jie, Chong, Dawn Q., Freedman, Neal D., Fuchs, Charles S., Gaziano, John Michael, Giovannucci, Edward, Graubard, Barry I., Hollenbeck, Albert R., Hou, Lifang, Jacobs, Eric J., King, Lindsay Y., Koshiol, Jill, Lee, I-Min, Linet, Martha S., Palmer, Julie R., Purdue, Mark P., Rosenberg, Lynn, Schairer, Catherine, Sesso, Howard D., Sigurdson, Alice J., Wactawski-Wende, Jean, Zeleniuch-Jacquotte, Anne, Campbell, Peter T., McGlynn, Katherine A. |
| author_facet | Petrick, Jessica L., Sahasrabuddhe, Vikrant V., Chan, Andrew T., Alavanja, Michael C., Beane-Freeman, Laura E., Buring, Julie E., Chen, Jie, Chong, Dawn Q., Freedman, Neal D., Fuchs, Charles S., Gaziano, John Michael, Giovannucci, Edward, Graubard, Barry I., Hollenbeck, Albert R., Hou, Lifang, Jacobs, Eric J., King, Lindsay Y., Koshiol, Jill, Lee, I-Min, Linet, Martha S., Palmer, Julie R., Purdue, Mark P., Rosenberg, Lynn, Schairer, Catherine, Sesso, Howard D., Sigurdson, Alice J., Wactawski-Wende, Jean, Zeleniuch-Jacquotte, Anne, Campbell, Peter T., McGlynn, Katherine A., Petrick, Jessica L., Sahasrabuddhe, Vikrant V., Chan, Andrew T., Alavanja, Michael C., Beane-Freeman, Laura E., Buring, Julie E., Chen, Jie, Chong, Dawn Q., Freedman, Neal D., Fuchs, Charles S., Gaziano, John Michael, Giovannucci, Edward, Graubard, Barry I., Hollenbeck, Albert R., Hou, Lifang, Jacobs, Eric J., King, Lindsay Y., Koshiol, Jill, Lee, I-Min, Linet, Martha S., Palmer, Julie R., Purdue, Mark P., Rosenberg, Lynn, Schairer, Catherine, Sesso, Howard D., Sigurdson, Alice J., Wactawski-Wende, Jean, Zeleniuch-Jacquotte, Anne, Campbell, Peter T., McGlynn, Katherine A. |
| author_sort | petrick, jessica l. |
| container_issue | 12 |
| container_start_page | 1156 |
| container_title | Cancer Prevention Research |
| container_volume | 8 |
| description | <jats:title>Abstract</jats:title> <jats:p>Chronic inflammation plays a pivotal role in the pathogenesis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), the two most common types of liver cancer. A number of prior experimental studies have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may potentially protect against liver cancer. However, no observational study has examined the association between aspirin duration and dose or other over-the-counter non-aspirin NSAIDs, such as ibuprofen, and liver cancer incidence. Furthermore, the association between NSAID use and risk of ICC is unclear. As part of the Liver Cancer Pooling Project, we harmonized data on 1,084,133 individuals (HCC = 679, ICC = 225) from 10 U.S.-based prospective cohort studies. Cox proportional hazards regression models were used to evaluate multivariable-adjusted HRs and 95% confidence intervals (CI). Current aspirin use, versus nonuse, was inversely associated with HCC (HR, 0.68; 95% CI, 0.57–0.81), which persisted when restricted to individuals not using non-aspirin NSAIDs and in a 5- and 10-year lag analysis. The association between aspirin use and HCC risk was stronger for users who reported daily use, longer duration use, and lower dosage. Ibuprofen use was not associated with HCC risk. Aspirin use was associated with a reduced ICC risk in men (HR, 0.64; 95% CI, 0.42–0.98) but not women (HR, 1.34; 95% CI, 0.89–2.01; Pinteraction = 0.01). The observed inverse association between aspirin use and liver cancer in our study, together with previous data, suggests the merit of future intervention studies of aspirin and other agents that affect chronic inflammatory pathways for HCC and possibly ICC. Cancer Prev Res; 8(12); 1156–62. ©2015 AACR.</jats:p> |
| doi_str_mv | 10.1158/1940-6207.capr-15-0126 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xOTQwLTYyMDcuY2Fwci0xNS0wMTI2 |
| imprint | American Association for Cancer Research (AACR), 2015 |
| imprint_str_mv | American Association for Cancer Research (AACR), 2015 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 1940-6207, 1940-6215 |
| issn_str_mv | 1940-6207, 1940-6215 |
| language | English |
| last_indexed | 2024-03-01T18:16:40.501Z |
| match_str | petrick2015nsaiduseandriskofhepatocellularcarcinomaandintrahepaticcholangiocarcinomathelivercancerpoolingproject |
| mega_collection | American Association for Cancer Research (AACR) (CrossRef) |
| physical | 1156-1162 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | American Association for Cancer Research (AACR) |
| record_format | ai |
| recordtype | ai |
| series | Cancer Prevention Research |
| source_id | 49 |
| spelling | Petrick, Jessica L. Sahasrabuddhe, Vikrant V. Chan, Andrew T. Alavanja, Michael C. Beane-Freeman, Laura E. Buring, Julie E. Chen, Jie Chong, Dawn Q. Freedman, Neal D. Fuchs, Charles S. Gaziano, John Michael Giovannucci, Edward Graubard, Barry I. Hollenbeck, Albert R. Hou, Lifang Jacobs, Eric J. King, Lindsay Y. Koshiol, Jill Lee, I-Min Linet, Martha S. Palmer, Julie R. Purdue, Mark P. Rosenberg, Lynn Schairer, Catherine Sesso, Howard D. Sigurdson, Alice J. Wactawski-Wende, Jean Zeleniuch-Jacquotte, Anne Campbell, Peter T. McGlynn, Katherine A. 1940-6207 1940-6215 American Association for Cancer Research (AACR) Cancer Research Oncology http://dx.doi.org/10.1158/1940-6207.capr-15-0126 <jats:title>Abstract</jats:title> <jats:p>Chronic inflammation plays a pivotal role in the pathogenesis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), the two most common types of liver cancer. A number of prior experimental studies have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin and ibuprofen, may potentially protect against liver cancer. However, no observational study has examined the association between aspirin duration and dose or other over-the-counter non-aspirin NSAIDs, such as ibuprofen, and liver cancer incidence. Furthermore, the association between NSAID use and risk of ICC is unclear. As part of the Liver Cancer Pooling Project, we harmonized data on 1,084,133 individuals (HCC = 679, ICC = 225) from 10 U.S.-based prospective cohort studies. Cox proportional hazards regression models were used to evaluate multivariable-adjusted HRs and 95% confidence intervals (CI). Current aspirin use, versus nonuse, was inversely associated with HCC (HR, 0.68; 95% CI, 0.57–0.81), which persisted when restricted to individuals not using non-aspirin NSAIDs and in a 5- and 10-year lag analysis. The association between aspirin use and HCC risk was stronger for users who reported daily use, longer duration use, and lower dosage. Ibuprofen use was not associated with HCC risk. Aspirin use was associated with a reduced ICC risk in men (HR, 0.64; 95% CI, 0.42–0.98) but not women (HR, 1.34; 95% CI, 0.89–2.01; Pinteraction = 0.01). The observed inverse association between aspirin use and liver cancer in our study, together with previous data, suggests the merit of future intervention studies of aspirin and other agents that affect chronic inflammatory pathways for HCC and possibly ICC. Cancer Prev Res; 8(12); 1156–62. ©2015 AACR.</jats:p> NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project Cancer Prevention Research |
| spellingShingle | Petrick, Jessica L., Sahasrabuddhe, Vikrant V., Chan, Andrew T., Alavanja, Michael C., Beane-Freeman, Laura E., Buring, Julie E., Chen, Jie, Chong, Dawn Q., Freedman, Neal D., Fuchs, Charles S., Gaziano, John Michael, Giovannucci, Edward, Graubard, Barry I., Hollenbeck, Albert R., Hou, Lifang, Jacobs, Eric J., King, Lindsay Y., Koshiol, Jill, Lee, I-Min, Linet, Martha S., Palmer, Julie R., Purdue, Mark P., Rosenberg, Lynn, Schairer, Catherine, Sesso, Howard D., Sigurdson, Alice J., Wactawski-Wende, Jean, Zeleniuch-Jacquotte, Anne, Campbell, Peter T., McGlynn, Katherine A., Cancer Prevention Research, NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project, Cancer Research, Oncology |
| title | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_full | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_fullStr | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_full_unstemmed | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_short | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| title_sort | nsaid use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project |
| title_unstemmed | NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1158/1940-6207.capr-15-0126 |